HKUCTR-2799
Untitled Trial
Phase II prospective study of bintrafusp alfa in previously treated patients with recurrent and metastatic (R/M) non-keratinizing nasopharyngeal carcinoma (NPC)
Dr. Chi-leung Chiang·Phase 2·HKU CLINICAL TRIALS REGISTRY·drugRecruiting
Study focus
- Disease/Condition
- Neoplasm
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Dr. Chi-leung Chiang
- Funder
- Merck Healthcare KGaA, Darmstadt, Germany
- Location
- China
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- Jan 30, 2023
ICD-10 classifications
NeoplasmsBenign neoplasmsIn situ neoplasmsPersonal history of other neoplasmsBenign neoplasm: Other specified sites
Data source
- Registry
- HKU CLINICAL TRIALS REGISTRY
- Trial ID
- HKUCTR-2799
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for HKUCTR-2799 through Pure Global AI's free database. This Phase 2 trial is sponsored by Dr. Chi-leung Chiang and is currently Recruiting. The study focuses on Neoplasm.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to HKU CLINICAL TRIALS REGISTRY data, helping medical device and pharmaceutical companies navigate clinical research efficiently.